Manufacturer of Controlled Substances Registration: Siegfried USA, LLC, 42539 [2015-17520]
Download as PDF
<![CDATA[
42539
Federal Register / Vol. 80, No. 137 / Friday, July 17, 2015 / Notices
Operations Industry Consortium, Inc.
(‘‘NCOIC’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Military Communication
Institute, Zegrze, Mazowieckie,
POLAND; and Real-Time Innovation,
Sunnyvale, CA, have withdrawn as
parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and NCOIC
intends to file additional written
notifications disclosing all changes in
membership.
On November 19, 2004, NCOIC filed
its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on February 2, 2005 (70
FR 5486).
The last notification was filed with
the Department on March 25, 2015. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on April 22, 2015 (80 FR 22550).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2015–17543 Filed 7–16–15; 8:45 am]
BILLING CODE P
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
DEPARTMENT OF JUSTICE
Antitrust Division
[FR Doc. 2015–17545 Filed 7–16–15; 8:45 am]
srobinson on DSK5SPTVN1PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—UHD Alliance, Inc., in Its
Capacity as a Standards Development
Organization
Notice is hereby given that, on June
17, 2015, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), UHD Alliance, Inc.,
in its capacity as a Standards
Development Organization (‘‘UHD
Alliance SDO’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing (1) the name and
principal place of business of the
standards development organization
and (2) the nature and scope of its
standards development activities. The
notifications were filed for the purpose
of invoking the Act’s provisions limiting
VerDate Sep<11>2014
20:59 Jul 16, 2015
the recovery of antitrust plaintiffs to
actual damages under specified
circumstances.
Pursuant to section 6(b) of the Act, the
name and principal place of business of
the standards development organization
is: UHD Alliance, Inc., Fremont, CA.
The nature and scope of UHD Alliance
SDO’s standards development activities
are as follows: UHD Alliance SDO is
organized and will be operated
primarily to create a framework to
enable the global industries interested
in premium next generation content
related technologies, such as Ultra High
Definition, High Dynamic Range, Wide
Color Gamut, High Frame Rate and Next
Gen Audio (‘‘Premium Next Gen
Content’’) to (a) specify and develop
requirements for the premium quality
Premium Next Gen Content, related
devices, distribution and other elements
of a UHD Alliance-based ecosystem
(‘‘Specifications’’); (b) promote the
global development and adoption of
Specifications and Specificationcompliant products (i.e., content,
devices, and services); (c) provide clear
definitions, industry guidelines and best
practices on emerging technologies and
collaborate with other standards
development organizations; (d) develop
and administer Premium Next Gen
Content testing methodologies and
certification programs based on the
Specifications; (e) establish a logo
program for Specification certified
products (i.e., content, devices and
services); and (f) promote the UHD
Alliance brand and ecosystem to
consumers.
Jkt 235001
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: Siegfried
USA, LLC
ACTION:
Notice of registration.
Siegfried USA, LLC applied to
be registered as a manufacturer of
certain basic classes of controlled
substances. The Drug Enforcement
Administration (DEA) grants Siegfried
USA, LLC registration as a manufacturer
of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated February 5, 2015, and published
SUMMARY:
PO 00000
Frm 00073
Fmt 4703
Sfmt 9990
in the Federal Register on February 11,
2015, 80 FR 7634, Siegfried USA, LLC,
33 Industrial Park Road, Pennsville,
New Jersey 08070 applied to be
registered as a manufacturer of certain
basic classes of controlled substances.
No comments or objections were
submitted to this notice.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of Siegfried USA, LLC to
manufacture the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the following basic
classes of controlled substances:
Controlled substance
Gamma
Hydroxybutyric
Acid
(2010).
Dihydromorphine (9145) ...............
Hydromorphinol (9301) .................
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Opium tincture (9630) ..................
Oxymorphone (9652) ...................
Schedule
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Dated: July 10, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–17520 Filed 7–16–15; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\17JYN1.SGM
17JYN1
]]>Agencies
[Federal Register Volume 80, Number 137 (Friday, July 17, 2015)]
[Notices]
[Page 42539]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-17520]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Manufacturer of Controlled Substances Registration: Siegfried
USA, LLC
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Siegfried USA, LLC applied to be registered as a manufacturer
of certain basic classes of controlled substances. The Drug Enforcement
Administration (DEA) grants Siegfried USA, LLC registration as a
manufacturer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice dated February 5, 2015, and
published in the Federal Register on February 11, 2015, 80 FR 7634,
Siegfried USA, LLC, 33 Industrial Park Road, Pennsville, New Jersey
08070 applied to be registered as a manufacturer of certain basic
classes of controlled substances. No comments or objections were
submitted to this notice.
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of Siegfried USA, LLC to manufacture
the basic classes of controlled substances is consistent with the
public interest and with United States obligations under international
treaties, conventions, or protocols in effect on May 1, 1971. The DEA
investigated the company's maintenance of effective controls against
diversion by inspecting and testing the company's physical security
systems, verifying the company's compliance with state and local laws,
and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above-named company is granted registration as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)........... I
Dihydromorphine (9145)..................... I
Hydromorphinol (9301)...................... I
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Codeine (9050)............................. II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
Oripavine (9330)........................... II
Thebaine (9333)............................ II
Opium tincture (9630)...................... II
Oxymorphone (9652)......................... II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
Dated: July 10, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-17520 Filed 7-16-15; 8:45 am]
BILLING CODE 4410-09-P
